1. The Changing Face of Multiple Sclerosis: What Are the Experts Looking Forward To?

3. This program will include a discussion of data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.

4. Introduction

5. MRI and MS

6. Dissemination Space and Time in CIS 2017 McDonald Criteria

7. MRI Rationale for Practical Guidelines

8. Brain Atrophy

9. MAGNIMS Recommendations

10. Normative Values for Rate of Brain Volume Changes Over the Lifespan: MAGNIMS

11. MS Pathophsyiology

12. MS Pathophsyiology T and B Cells

13. Imbalances Regulatory Network

14. Architecture of the Immune System

15. What Is Needed to Deal With Progression in MS? Faculty Perspective

16. Possible Mechanisms of Neuroprotection and Repair

17. DMTs in MS

18. Selecting Therapy in Clinical Practice Faculty Perspective

19. First European Treatment Guidelines ECTRIMS/EAN

20. Clinical Practice Goals

21. NEDA Faculty Opinion

22. Lifestyle Changes

23. Progressive MS Faculty Perspective

24. Precision Medicine in MS? Faculty Opinion

25. Abbreviations